Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Methergin Ampoules°


Contraindicated
Uterotonic, risk of miscarriage or premature labor

Contraindicated
Intoxication in breastfed infants
Methergin Ampoules° :
Type Medicine Withdrawn
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Manufacturer Novartis Pharma AG
Origin Switzerland
ATC G02AB01

Your comment will appear shortly after approval

Methergin Ampoules° :

Revision Date : 01/01/2016


Effect Frequency
Abdominal pain Common
Anaphylactic reactions Very rare
Angina pectoris Not known
Arterial spasm Rare
Arteriospasm coronary Very rare
Atrioventricular block (AVB) Not known
Bradycardia Rare
Cerebrovascular accident Not known
Chest pain Uncommon
Convulsion Uncommon
Diarrhoea (Diarrhea) Very rare
Hallucination Very rare
Headache Common
Hyperhidrosis Uncommon
Hypertension Common
Hypotension Uncommon
Lightheadedness Uncommon
Muscle spasms Very rare
Myocardial infarction Very rare
Nasal congestion Very rare
Nausea Uncommon
Palpitations Rare
Paraesthesia (paresthesia) Not known
Skin Eruption Common
Tachycardia Rare
Thrombophlebitis Very rare
Tinnitus Very rare
Vasoconstriction Rare
Vasospasm Rare
Ventricular fibrillation Not known
Ventricular tachycardia Not known
Vomiting Uncommon

Different Units By MoH Code

Revision Date : 01/11/2012

Revision Date : 13/04/2005

Methergin Ampoules°  MoH 835 :
Form Solution for injection
Packaging Ampoules
Package Size 5x1ml
Strength 0.2mg/ml
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 20681
Submission date 01/01/1972
Registration Year 1972
Withdrawn Date 2014


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info